Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Cash (2016 - 2025)

Historic Change in Cash for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to -$256000.0.

  • Arcadia Biosciences' Change in Cash rose 8367.35% to -$256000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 5781.27%. This contributed to the annual value of -$2.3 million for FY2024, which is 8388.79% up from last year.
  • Per Arcadia Biosciences' latest filing, its Change in Cash stood at -$256000.0 for Q3 2025, which was up 8367.35% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Change in Cash ranged from a high of $16.8 million in Q1 2021 and a low of -$9.5 million during Q2 2023
  • For the 5-year period, Arcadia Biosciences' Change in Cash averaged around -$785421.1, with its median value being -$1.8 million (2025).
  • Per our database at Business Quant, Arcadia Biosciences' Change in Cash soared by 26885.43% in 2021 and then plummeted by 29346.8% in 2023.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Change in Cash stood at -$6.8 million in 2021, then soared by 69.67% to -$2.1 million in 2022, then plummeted by 97.25% to -$4.1 million in 2023, then surged by 107.48% to $306000.0 in 2024, then plummeted by 183.66% to -$256000.0 in 2025.
  • Its Change in Cash stands at -$256000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.1 million for Q1 2025.